Hyro Competitive Intelligence & Landscape

Hyro (hyro.ai) is a pioneering company specializing in Responsible AI Agents for Healthcare, founded in 2018 by Israel Krush and Rom Cohen [https://www.hyro.ai/careers/][https://www.hyro.ai/blog/series-b-announcement-responsible-ai/]. Headquartered in both New York and Tel Aviv, Hyro is dedicated to transforming healthcare communication by enabling organizations to automate repetitive tasks, improve patient access, and enhance operational efficiencies [https://hyro.ai/][https://www.hyro.ai/careers/]. The company’s mission is to empower healthcare enterprises to strengthen patient relationships through AI-powered communications, leading to what they term "HY-ROI" – satisfied patients, better operational efficiencies, and maximized returns [https://www.hyro.ai/about-us/].

Hyro offers an Adaptive Communications Platform that provides omnichannel capabilities and analytics to manage an unlimited volume of calls and messages, while automatically gathering crucial business insights [https://www.hyro.ai/platform/]. Their core products include AI Agents designed to resolve repetitive tasks, Call Center Automation to shield staff from routine inquiries, Conversational Intelligence for actionable insights, and Proactive Px™ for scalable outbound patient engagement [https://hyro.ai/]. These solutions are seamlessly integrated with major systems like Epic EMR, Salesforce, Cisco, and Five9, ensuring comprehensive coverage across various healthcare workflows [https://hyro.ai/].

Hyro's target market primarily includes healthcare providers, FQHCs, children's hospitals, and healthcare payers [https://hyro.ai/]. They offer specialized skills such as ARMR™ Outreach for coverage loss protection, Scheduling Management, IT Help Desk deflection, Spot™ for enhanced site search, Physician Search, Rx Management, and FAQ Resolution [https://hyro.ai/]. The company emphasizes Responsible AI, minimizing risks for healthcare organizations and patients [https://hyro.ai/]. With significant funding rounds, including a $45 million growth funding round in October 2025 and a Series B extension bringing total funding to $50 million, Hyro is positioned for continued expansion in the healthcare AI sector [https://www.hyro.ai/blog/hyro-ai-agents-for-healthcare-raise-45-million/][https://www.hyro.ai/blog/healthier-capital-invests-in-hyros-responsible-ai-agents-for-healthcare/].

Hyro has garnered industry recognition, being named a Fierce Healthcare Innovation Awards 2025 Winner and included in CB Insights Digital Health 50 for 2025 [https://www.hyro.ai/press/]. They have also been featured in top-tier publications such as the Wall Street Journal, Newsweek, and Becker’s Hospital Review [https://www.hyro.ai/press/]. The company actively fosters partnerships with technology vendors, global systems integrators, and consulting firms, leveraging its industry-leading natural language engine to deploy digital front door use cases across various channels including websites, call centers, mobile apps, and SMS [https://www.hyro.ai/partnerships/].

Hyro (hyro.ai) specializes in agentic AI solutions designed specifically for the healthcare sector, focusing on improving patient access and alleviating staff burdens. Their platform offers out-of-the-box AI agents that automate repetitive tasks across various communication channels, including call centers, websites, and SMS. Key products include Call Center Automation for deflecting routine calls, Proactive Px™ for outbound patient engagement, and specialized AI agents like Spot™ for GPT-powered site search and Rx Management for prescription refills.

Hyro's approach emphasizes rapid deployment and achieving a 60x faster time to value with "intent-less AI agents" that require no extensive training data, meaning no heavy lifting for clients to implement.

While Hyro doesn't publicly list specific pricing plans or tiers, their solutions are clearly positioned for enterprise healthcare organizations, including providers, FQHCs, children's hospitals, and payers. They provide an ROAI Calculator on their website to help potential clients measure the return on investment from implementing their AI agents, emphasizing cost savings in areas like call center operations by resolving or deflecting a significant percentage of calls and reducing the cost per call. This suggests a value-based pricing model rather than fixed, public tiers, where the cost is tied to the measurable benefits and efficiencies gained.

Hyro's offering includes a free 30-day trial for their Spot™ AI agent, which enhances site search capabilities by funneling unlimited web pages and FAQs into a no-code interface for instant activation. This trial allows organizations to experience the benefits of their GPT-powered search solution firsthand. The company also provides an RFP Template for Responsible AI Agents, a structured framework designed to help healthcare organizations efficiently navigate the procurement process and evaluate AI solutions tailored to their specific needs. This resource further indicates a focus on helping large-scale healthcare systems make informed purchasing decisions for advanced AI capabilities.

Hyro, an innovator in AI Agents for Healthcare, demonstrates consistent growth and a strategic focus on expanding its market reach and technological capabilities, as evidenced by its current hiring trends. The company actively seeks talent across its main locations in New York City and Tel Aviv, indicating a commitment to both its commercial growth and its foundational engineering and product development efforts [hyro.ai/careers/]. The term "SuperHyro" is frequently used in job postings, highlighting a company culture that values high-performing individuals ready to contribute significantly to the healthcare AI landscape [hyro.ai/careers/].

Hiring patterns at Hyro reveal a strong emphasis on roles that directly support its core offerings: AI Agents for Healthcare and Conversational AI. Current notable openings include a Senior AI Engineer in Tel Aviv-Yafo and a Content QA Analyst, also in Tel Aviv-Yafo, underscoring the company's continuous investment in enhancing its AI solutions and ensuring quality [hyro.ai/careers/E3.B63/][hyro.ai/careers/C6.B63/]. On the product side, Hyro is recruiting a Senior Product Analyst in Tel Aviv-Yafo and a Product Manager, indicating a focus on product innovation and market analysis [hyro.ai/careers/9D.86F/][hyro.ai/careers/]. The presence of a Talent Acquisition Specialist among their team further signifies a deliberate and ongoing strategy for talent attraction [hyro.ai/careers/].

In addition to engineering and product roles, Hyro is actively scaling its sales and partnership teams. Key sales leadership positions such as RVP of Sales and CRO in New York, and VP of Sales Development in Tel Aviv-Yafo, reflect a strong drive to expand customer acquisition and revenue generation [hyro.ai/careers/7B.96B/][hyro.ai/careers/3A.66D/][hyro.ai/careers/BD.86F/]. Furthermore, the search for a Strategic Partnerships Director in New York suggests a focus on forging alliances and expanding its ecosystem, crucial for a company operating in a complex sector like healthcare [hyro.ai/careers/F4.764/]. There is no publicly available information on layoffs at Hyro, and the consistent posting of new and senior-level positions across different departments points towards a stable and growth-oriented trajectory.

Since its founding in 2018, Hyro (hyro.ai) has demonstrated robust financial growth and successful fundraising, securing a total of $95 million in funding to date [https://www.hyro.ai/about-us/]. This significant capital has been raised through multiple rounds from a diverse group of investors, including Healthier Capital, Norwest, Define Ventures, ServiceNow Ventures, and Macquarie Capital [https://www.hyro.ai/blog/hyro-a-fierce-15-company-of-2026/]. The company's strong performance and product-market fit have enabled it to double its valuation with its recent strategic growth rounds [https://www.hyro.ai/blog/what-our-45m-round-means-for-healthcare-access/].

Hyro's fundraising journey includes a $10.5 million Series A funding round, led by Spero Ventures with participation from Twilio Inc., Mindset Ventures, and R-squared ventures [https://www.hyro.ai/blog/we-just-raised-our-10-5m-series-a-next-stop-replacing-intent-based-solutions-with-adaptive-communications/]. This was followed by a $20 million Series B round, which included new investors like Macquarie Capital and Liberty Mutual Strategic Ventures, aimed at advancing Responsible AI-powered communications for enterprises [https://www.hyro.ai/blog/series-b-announcement-responsible-ai/]. The company further bolstered its financial position with an extension to its Series B funding led by Healthier Capital, bringing its total raised to $50 million by December 2024 [https://www.hyro.ai/blog/healthier-capital-invests-in-hyros-responsible-ai-agents-for-healthcare/].

A pivotal moment for Hyro's financial trajectory occurred in October 2025, when it announced $45 million in new growth funding, led by Healthier Capital, with continued participation from Norwest and Define Ventures [https://www.hyro.ai/blog/hyro-ai-agents-for-healthcare-raise-45-million/]. This round also saw new strategic investments from Bon Secours Mercy Health, a long-standing client, and ServiceNow Ventures [https://www.hyro.ai/blog/hyro-ai-agents-for-healthcare-raise-45-million/]. This latest infusion of capital underscores Hyro's market leadership in AI Agents for Healthcare and its ability to attract significant investment to accelerate its mission [https://www.hyro.ai/blog/what-our-45m-round-means-for-healthcare-access/].

Hyro's financial health indicators are strong, with the company enabling substantial annual savings for its clients, often exceeding $300,000 annually, and in some cases, saving clients $1,000,000 almost immediately [https://hyro.ai/]. These impressive return on investment (ROI) figures are partly attributed to its Patient Intelligence Dashboard, which provides real-time analytics and tangible results for healthcare organizations [https://www.hyro.ai/blog/what-our-45m-round-means-for-healthcare-access/]. The company's consistent ability to secure funding and deliver measurable value to its clients positions it as a robust and growing entity within the competitive healthcare AI landscape.

Hyro (hyro.ai) actively participates in and hosts a variety of industry events, demonstrating its commitment to advancing AI agents in healthcare. They frequently attend prominent in-person conferences such as the Healthcare Interactive Conference (HCIC), which focuses on digital health and patient experience, and the Next Generation Patient Experience (NGPX), a gathering for patient experience leaders. Additionally, Hyro is present at specialized events like the Annual Conference of Healthcare Contact Centers, where their executives showcase how responsible AI agents can enhance the patient journey and drive efficiency.

Hyro also makes its mark at major industry trade shows like ViVE, where their booth generated considerable buzz around patient access and agentic AI, and the HIMSS Global Health Conference & Exhibition. For those unable to attend in person, Hyro frequently offers post-conference briefings, such as the "Post-ViVE and HIMSS Briefing: Agentic AI and the Future of Patient Access" webinar, to disseminate key insights and themes directly to healthcare leaders. They also participate in showcases like the PAC Industry Partner Showcase, spotlighting their responsible AI agents.

Beyond in-person events, Hyro hosts and features in numerous webinars and on-demand content, providing valuable resources for the healthcare community. Notable webinars include "First Look: Healthcare Voice Agent Benchmark Results," "Decoding Agentic AI: What Healthcare Leaders Need to Know," and "Inside the 2026 State of Patient Communications Report." They also co-host significant virtual gatherings like "The Healthcare Engagement Summit 2025," which they hosted with TytoCare, exploring innovative strategies for patient engagement across payers and providers [https://www.hyro.ai/events/]. Through these diverse engagements, Hyro solidifies its position as a thought leader and innovator in healthcare AI.